In Vivo Prevention of Murine GVHD

小鼠 GVHD 的体内预防

基本信息

  • 批准号:
    10362877
  • 负责人:
  • 金额:
    $ 60.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-01 至 2027-06-30
  • 项目状态:
    未结题

项目摘要

8:4:A9B;9:/72/999-+03/C.-1/1-039791091.93 0-0>-1-.1-03-/3-0/-++093D3/9+.0/1>D 0&8#"L)9M:N;O&)#0P":#8$6'Q8M)RSN;):&#2S$2':#7T2U"7M-?'NS"Q-/-013.9-309995390K9./09?+ 0.92-/96+ /0 9 I I I I I I I I I I 089:2;9920<09+8=,-7299.9/9->0033/-/0..-/.-/013207993-/0-3//7.4/-3/5063-3?/5-8419@7 185 .98 2?-+4.4/41-35-.+--00+/0-0/0093-//D?1D+309/3//19-0/--3309/D1?9-++1.-.9101/3-9702493;?13/9+0D./9911/-199//-.D3-9/93+.-09.1.1931107/0911-3031-EF9G?-H03I9-/0-+0+3301909/9>3/-003093>D ,2;00Z/[<-/D9[K799S-20N0./S-7."/890Q77-/9'0-W\?00&V9#+1"56L)0M+.N@O9&915-273)53#-/P98V"#0;9$-.0'9Q;M09)3/33R0-S.N0)9?U1/",8M-93'9/N<S3-".9/Q037-;9.03/-D/D7-1<?-20;-000/9D7321//9909/097W-0 : 3/8-Y9-003/1X;2C//9D977W 4V6 ,2/<9920/-787/-0VW@154=+9676X2W1900]99//9-0203/-//9?; 0.9829/9399/7. ;-/D7 9C=X ;0/D7 <2 Y-03/1;97 V V @ 0K9./09?+ 0.92-/9;0933-01,-3/-./37 = ;0/D70 9 2//97 = 0-0.97 012456789 4 9 64 5 !"#$ &'()* "0C!444445"19#724481494$04!10%2;1310218443!591B457#82719"181"942!11281;0019188938898444190C8929;;;;""838<3?;4#24&;522'1C5@1(@@2;*@4+AA,;-8=.,"/849101-."2+,4$45891<109<299('8201'9,9(4:(34==$#9(131193924882599981291111428188824888394::9<2244494662814995888941819<29919892261214495414820<<421522889BB926488190699421215>9884334494222711838492271 ;18748 F98<2199889 #491 838684<2188 21 #"4D5C!9 E"<;"D<#"D =D# #1348482 292012>9 D2911295:98:G2C849444441 ===888999111888:::222666"<08;<481241384414<44892C8 ###444999111 888333888666888444<<<222111888888 222111 HIJKLNJOPQRLSTUVWJXWYYZ [R \WZ ]4X^6W4V_YYWl`9SLP3R8W6`814RZ8W9a`48P4Rb32W2T8V9SL1c99R695Yc19WjZ9_9IJ41K9L438W8J85O1:P9QR8L1S1T9ZV9W4J45T4WY9Y&Z5d'9Y(SZ*V+O4,W4-Y.R,2e/09V-_.6+1W2,5PW1f04S2Z9(VP'K9V0S3'R8L,1(L:(I73J8(O38Wk9PR^9V_WZ`WTS^STTWYYYSLWgZh^PRJ V_W^RYYReSLfYSZVi □ 0C mno9@mp@p@;129D41234@ppop@pm # "2@npqB@@@A 0439m rRPJsKfWtuTRLVSLIWa " 54989414984v+8w2w+x.7,224239926698y989:44412z3442z8
8:4:A9B;9:/72/999-+03/C.-1/1-039791091.93 0-0>-1-.1-03-/3-0/-++093D3/9+.0/1>D 0&8#"L)9M:N;O&)#0P":#8$6'Q8M)RSN;):&#2S$2':#7T2U"7M-?'NS"Q-/-013.9-309995390K9./09?+ 0.92-/96+ /0 9 我 我我 我我 我 我我 我我 089:2;9920<09+8=,-7299.9/9->0033/-/0..-/.-/013207993-/0-3//7.4/-3/5063-3?/5-8419@7 185 .98 2?-+4.4/41-35-.+--00+/0-0/0093-//D?1D+309/3//19-0/--3309/D1?9-++1.-.9101/3-9702493;?13/9+ 0D./9911/-199//-.D3-9/93+.-09.1.1931107/0911-3031-EF9G?-H03I9-/0-+0+3301909/9>3/-003093>D ,2;00Z/[<-/D9[K799S-20N0./S-7."/890Q77-/9'0-W\?00&V9#+1"56L)0M+.N@O9&915-273)53#-/P98V"#0;9$- .0'9Q;M09)3/33R0-S.N0)9?U1/",8M-93'9/N<S3-".9/Q037-;9.03/-D/D7-1<?-20;-000/9D7321//9909/097W-0 :3/8-Y9-003/1X;2C//9D977W 4V6 ,2/<9920/-787/-0VW@154=+9676X2W1900]99//9-0203/-//9?; 0.9829/9399/7。 ;-/D7 9C=X ;0/D7 <2 Y-03/1;97 V V @ 0K9./09?+ 0.92-/9;0933-01,-3/-./37 = ;0/D70 9 2//97 = 0-0.97 012456789 4 9 64 5 !"#$ &'()* “0C!444445”19#724481494$04!10%2;1310218443!591B457#82719“181”942!11281;00191889388984 44190C8929;;;;""838<3?;4#24&;522'1C5@1(@@2;*@4+AA,;-8=.,"/849101-."2+,4$45891<109<299 ('8201'9,9(4:(34==$#9(131193924882599981291111428188824888394::9<22444946628149958889 41819<29919892261214495414820<<421522889BB926488190699421215>9884334494222711838492271 ;18748 F98<2199889 #491 838684<2188 21 #"4D5C!9 E"<;"D<#"D =D# #1348482 292012>9 D2911295:98:G2C849444441 ===888999111888:::222666"<08;<481241384414<44892C8 ###444999111 888333888666888444<<<222111888888 222111 HIJKLNJOPQRLSTUVWJXWYYZ [R \WZ ]4X^6W4V_YYWl`9SLP3R8W6`814RZ8W9a`48P4Rb32W2T8V9SL1c99R695Yc19WjZ9_9IJ41K9L438W8J85O1:P9QR8L1S1T9ZV9W4J45T4WY9Y &Z5d'9Y(SZ*V+O4,W4-Y.R,2e/09V-_.6+1W2,5PW1f04S2Z9(VP'K9V0S3'R8L,1(L:(I73J8(O38Wk9PR^9V_WZ`WTS^STTWYYYSLWgZh^PRJ) V_W^RYYReSLfYSZVi □ 0C mno9@mp@p@;129D41234@ppop@pm # "2@npqB@@@A 0439m RPJsKfWtuTRLVSLIW “ 54989414984v+8w2w+x.7,224239926698y989:44412z3442z8

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bruce R Blazar其他文献

Challenges and solutions for cellular therapy development in autoimmune diseases
自身免疫性疾病中细胞治疗发展的挑战与解决方案
  • DOI:
    10.1016/s2665-9913(24)00274-1
  • 发表时间:
    2024-11-01
  • 期刊:
  • 影响因子:
    16.400
  • 作者:
    Elizabeth R Volkmann;John Varga;Bruce R Blazar;Steven Z Pavletic
  • 通讯作者:
    Steven Z Pavletic
Five-Year Outcomes of the “Abatacept Combined with a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease (GVHD) Prophylaxis: A Randomized Controlled Trial” (‘ABA2‘)
  • DOI:
    10.1182/blood-2024-205130
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Lev Gorfinkel;Muna Qayed;Brandi Bratrude;Kayla Betz;Kyle Hebert;Sung W. Choi;Jeffrey Davis;Christine Duncan;Roger H. Giller;Michael S. Grimley;Andrew Harris;David A Jacobsohn;Nahal Lalefar;Nosha Farhadfar;Michael A. Pulsipher;Shalini Shenoy;Aleksandra Petrovic;Kirk R. Schultz;Gregory Yanik;Bruce R Blazar
  • 通讯作者:
    Bruce R Blazar
IL-33 Induces Paneth Cell Production of EGF and Soluble ST2, Regulating Epithelial Regeneration after Intestinal Injury
  • DOI:
    10.1182/blood-2023-191189
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Marco Calafiore;YA-Yuan Fu;Paola Vinci;Viktor Arnhold;Winston Chang;Suze Jansen;Anastasiya Egorova;Shuichiro Takashima;Jason Kuttiyara;Takahiro Ito;Jonathan Serody;Susumu Nakae;Heth Turnquist;Johan van Es;Hans Clevers;Caroline A. Lindemans;Bruce R Blazar;Alan M. Hanash
  • 通讯作者:
    Alan M. Hanash
Cyclosporine and Voclosporin Resistant Immune Effector Cells to Improve Outcomes after Stem Cell Transplantation
  • DOI:
    10.1182/blood-2023-180218
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Holly Wobma;Jiayi Dong;Francesca Alvarez Calderon;Xianliang Rui;Katherine Michaelis;Bruce R Blazar;Victor Tkachev;Ulrike Gerdemann;Leslie Kean
  • 通讯作者:
    Leslie Kean
Mitochondrial Pyruvate Carrier Inhibition Mitigates Murine Chronic Graft Versus Host Disease By Attenuating the Germinal Center Reaction
  • DOI:
    10.1182/blood-2023-185200
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Fathima A Mohamed;Stephanie Y Rhee;Joanna Ly;Ethan G Aguilar;Haley Melin;Peter T Sage;Tanner Schumacher;Govindarajan Thangavelu;Michael C Zaiken;Juan Liu;Venkatram Mereddy;Jason W Locasale;Bruce R Blazar
  • 通讯作者:
    Bruce R Blazar

Bruce R Blazar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bruce R Blazar', 18)}}的其他基金

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)
明尼苏达大学临床与转化科学研究所 (UMN CTSI)
  • 批准号:
    10763967
  • 财政年份:
    2023
  • 资助金额:
    $ 60.35万
  • 项目类别:
Metabolomics of cGVHD
cGVHD 的代谢组学
  • 批准号:
    10698171
  • 财政年份:
    2022
  • 资助金额:
    $ 60.35万
  • 项目类别:
In Vivo Prevention of Murine GVHD
小鼠 GVHD 的体内预防
  • 批准号:
    10610863
  • 财政年份:
    2022
  • 资助金额:
    $ 60.35万
  • 项目类别:
Metabolomics of cGVHD
cGVHD 的代谢组学
  • 批准号:
    10493800
  • 财政年份:
    2022
  • 资助金额:
    $ 60.35万
  • 项目类别:
Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease
利用 VISTA 途径预防急性 GVHD 和控制类固醇难治性疾病
  • 批准号:
    10560605
  • 财政年份:
    2021
  • 资助金额:
    $ 60.35万
  • 项目类别:
Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease
利用 VISTA 途径预防急性 GVHD 和控制类固醇难治性疾病
  • 批准号:
    10092348
  • 财政年份:
    2021
  • 资助金额:
    $ 60.35万
  • 项目类别:
Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease
利用 VISTA 途径预防急性 GVHD 和控制类固醇难治性疾病
  • 批准号:
    10348683
  • 财政年份:
    2021
  • 资助金额:
    $ 60.35万
  • 项目类别:
Nongenotoxic conditioning for gene therapy and allogeneic transplantation in Fanconi anemia
范可尼贫血基因治疗和同种异体移植的非基因毒性调理
  • 批准号:
    10305635
  • 财政年份:
    2019
  • 资助金额:
    $ 60.35万
  • 项目类别:
Nongenotoxic conditioning for gene therapy and allogeneic transplantation in Fanconi anemia
范可尼贫血基因治疗和同种异体移植的非基因毒性调理
  • 批准号:
    10656502
  • 财政年份:
    2019
  • 资助金额:
    $ 60.35万
  • 项目类别:
Nongenotoxic conditioning for gene therapy and allogeneic transplantation in Fanconi anemia
范可尼贫血基因治疗和同种异体移植的非基因毒性调理
  • 批准号:
    9888096
  • 财政年份:
    2019
  • 资助金额:
    $ 60.35万
  • 项目类别:

相似海外基金

Development of Teat-Dipping Nanoemulsion Loaded with Curcumin for Prevention of Intramammary Infection and Treatment of Mastitis as an Immune Stimulant
开发含有姜黄素的乳头浸渍纳米乳作为免疫兴奋剂预防乳房内感染和治疗乳腺炎
  • 批准号:
    24K09263
  • 财政年份:
    2024
  • 资助金额:
    $ 60.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
  • 批准号:
    MR/X032809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.35万
  • 项目类别:
    Fellowship
Developing new tests and treatments to enable prevention of osteoarthritis.
开发新的测试和治疗方法以预防骨关节炎。
  • 批准号:
    MR/Y003470/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.35万
  • 项目类别:
    Fellowship
Transforming child mental health: co-designing, building and evaluating a digitally enabled, personalised, prevention pathway
改变儿童心理健康:共同设计、构建和评估数字化、个性化的预防途径
  • 批准号:
    MR/X034917/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.35万
  • 项目类别:
    Fellowship
Prediction, Monitoring and Personalized Recommendations for Prevention and Relief of Dementia and Frailty
预防和缓解痴呆症和衰弱的预测、监测和个性化建议
  • 批准号:
    10103541
  • 财政年份:
    2024
  • 资助金额:
    $ 60.35万
  • 项目类别:
    EU-Funded
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
  • 批准号:
    502786
  • 财政年份:
    2024
  • 资助金额:
    $ 60.35万
  • 项目类别:
    Directed Grant
A digital tool to support pregnancy planning, preparation and prevention
支持怀孕计划、准备和预防的数字工具
  • 批准号:
    MR/Y503320/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.35万
  • 项目类别:
    Research Grant
Adaptation and Feasibility assessment of a primary suicide prevention intervention for school adolescents in Nigeria
尼日利亚学校青少年初级自杀预防干预措施的适应性和可行性评估
  • 批准号:
    MR/Y01958X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.35万
  • 项目类别:
    Research Grant
PFI-TT: Chemical Synthesis of a Natural Product Family of Compounds for Tick-Targeted Prevention and Control
PFI-TT:用于蜱目标预防和控制的天然产物化合物家族的化学合成
  • 批准号:
    2345757
  • 财政年份:
    2024
  • 资助金额:
    $ 60.35万
  • 项目类别:
    Standard Grant
Integrating universal and tailored approaches across the continuum of mental health and substance use supports: Supporting the implementation and coordination of the Icelandic Prevention Model and Integrated Youth Services
在心理健康和药物滥用支持的连续过程中整合通用和量身定制的方法:支持冰岛预防模式和综合青年服务的实施和协调
  • 批准号:
    477940
  • 财政年份:
    2024
  • 资助金额:
    $ 60.35万
  • 项目类别:
    Salary Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了